1. Home
  2. DTSS vs LEXX Comparison

DTSS vs LEXX Comparison

Compare DTSS & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.69

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

N/A

Current Price

$3.49

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTSS
LEXX
Founded
2014
2004
Country
China
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
6.7M
IPO Year
2026
2011

Fundamental Metrics

Financial Performance
Metric
DTSS
LEXX
Price
$0.69
$3.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 205.8K
54.6K
Earning Date
11-12-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $705,923.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6,915.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 52.05
52 Week Low
$0.52
$0.35
52 Week High
$2.29
$21.60

Technical Indicators

Market Signals
Indicator
DTSS
LEXX
Relative Strength Index (RSI) 51.23 48.88
Support Level $0.54 $2.67
Resistance Level $0.75 $3.90
Average True Range (ATR) 0.06 0.39
MACD 0.02 0.22
Stochastic Oscillator 58.04 88.81

Price Performance

Historical Comparison
DTSS
LEXX

About DTSS Datasea Inc.

Datasea Intelligent Technology Ltd, formerly known as Datasea Inc, is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: